Analyst Says Selecta Biosciences’ Gout Candidate Can Potentially Raise The Bar On Several Fronts

Canaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ: SELB) from $9 to $10 while maintaining the Buy rating ahead of the upcoming data from two Phase 3 studies of SEL-2...

C16 Biosciences Has Built A Palm Oil Farm In Midtown Manhattan To Stop Global Deforestation

C16 Biosciences founders in the company’s office in Manhattan, NY. C16 Biosciences Shara Ticku was boarding a flight to Singapore for a work trip when her company handed her a stack of N95 masks. This...

Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug

Shares of Arcus Biosciences Inc. RCUS, -27.76% were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that...